Reducing the health, social and economic burden of injecting drug use in Australia

减少澳大利亚注射吸毒造成的健康、社会和经济负担

• 批准号: nhmrc : 1001144
• 负责人: Prof Alison Ritter
• 金额: $ 173.77万
• 依托单位: Macfarlane Burnet Institute for Medical Research and Public Health
• 依托单位国家: 澳大利亚
• 项目类别: Centres of Research Excellence
• 财政年份: 2010
• 资助国家: 澳大利亚
• 起止时间: 2010-01-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/reducing-health-social-use-australia/76038
• 关键词: Reducing; health; social; economic; burden

Injecting drug use (IDU) is a disproportionately large source of health and social harm. This CRE unites Australia’s leading scientists in the IDU field – researchers working on blood-borne virus epidemiology and treatment, overdose prevention, justice health and psychiatric health - and experts from key non-government organisations. The CRE will develop new ways to improve the health of injecting drug users, and reduce the health and social burden of IDU to the Australian community.

注射吸毒是造成健康和社会危害的一个不成比例的大来源。该CRE联合了澳大利亚在IDU领域的领先科学家-从事血液传播病毒流行病学和治疗，过量预防，司法健康和精神健康的研究人员-以及来自主要非政府组织的专家。CRE将开发新的方法来改善注射毒品使用者的健康，并减轻注射毒品使用者对澳大利亚社区的健康和社会负担。